Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Balance Therapeutics

Balance Therapeutics
2009 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series C LATEST DEAL TYPE
$25M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of pharmaceutical therapies designed to address neurological disabilities resulting from excess inhibition of the brain. The company's pharmaceutical therapies offer a pharmacological approach to address cognitive deficits related to Down syndrome and Alzheimer's disease, enabling patients to get advanced therapy for their diseases and recover at a faster rate.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Pharmaceuticals
Primary Office
  • 1250 Bayhill Drive
  • Suite 125
  • San Bruno, CA 94066
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Balance Therapeutics’s full profile, request a free trial.

Balance Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 17-Feb-2016 $25M 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series B) 19-May-2015 00.000 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series A) 18-Mar-2015 0000 0000 000.00 Completed Generating Revenue
3. Grant 01-Jan-2012 00.00 0000 Completed Startup
2. Early Stage VC (Series A) 01-Feb-2011 $11M $11M 000.00 Completed Startup
1. Grant 01-Jan-2011 $363K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Balance Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 13,469,555 $0.001000 $0.06 $1 $1 1x $1 25.11%
To view this company’s complete Cap Table, request access »

Balance Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Oakmont (Los Angeles) Family Office Minority 000 0000 000000 0
Rock Springs Capital Hedge Fund Minority 000 0000 000000 0
Mohr Davidow Ventures Venture Capital Minority 000 0000 000000 0
OrbiMed Venture Capital Minority 000 0000 000000 0
Pappas Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Balance Therapeutics Executive Team (10)

Name Title Board
Seat
Contact
Info
Lyndon Lien Ph.D President, Chief Executive Officer and Board Member
Xiao-Xiong Lu Ph.D Vice President, Technical Operations
Herb Cross Chief Financial Officer

7 Former Executives

You’re viewing 3 of 10 executives. Get the full list »

Balance Therapeutics Board Members (10)

Name Representing Role Since Contact
Info
Carl Gordon Ph.D OrbiMed Board Member 000 0000
Ernest Mario Ph.D Pappas Capital Board Member 000 0000
Lyndon Lien Ph.D Balance Therapeutics President, Chief Executive Officer and Board Member 000 0000
Michael Grey Pappas Capital Board Member 000 0000
Peter Carlton Oakmont (Los Angeles) Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »